Unraveling Parkinson's Disease: A Comprehensive Overview for Healthcare Professionals
OthersPage Navigation
Introduction
Parkinson's disease (PD) is a chronic, progressive neurodegenerative disorder that primarily affects movement. Characterized by the degeneration of dopaminergic neurons in the substantia nigra, PD presents a complex clinical challenge necessitating a comprehensive understanding by healthcare professionals.
Etiology and Pathophysiology
While the exact cause of PD remains unknown, it is thought to result from a combination of genetic and environmental factors. Pathophysiologically, the loss of dopaminergic neurons leads to an imbalance in the basal ganglia's neurotransmitter levels, resulting in the motor symptoms of PD.
Clinical Manifestations
PD typically manifests with bradykinesia, rigidity, and resting tremor. Non-motor symptoms such as autonomic dysfunction, cognitive impairment, and mood disorders may also be present. The disease is progressive, with symptoms worsening over time.
Diagnosis
Diagnosis of PD is primarily clinical, based on the presence of cardinal motor symptoms and response to dopaminergic therapy. Neuroimaging can support the diagnosis, but it is not routinely used due to its limited sensitivity and specificity.
Treatment
Management of PD involves pharmacological therapy to enhance dopaminergic function, alongside non-pharmacological interventions such as physical therapy. Deep brain stimulation may be considered in advanced cases.
Conclusion
In conclusion, Parkinson's disease is a complex neurodegenerative disorder that requires a comprehensive and multidisciplinary approach to management. As healthcare professionals, it is essential to stay updated on the latest advancements in PD research to provide optimal care to our patients.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.
2.
According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.
3.
When Healthcare Chatbots Fall Short of Human Connection
4.
Even a few mutated cells can significantly impact how blood cancers develop, study finds
5.
Recently released national data on drug use and abuse among Americans.
1.
Understanding Bone Metastases: How Long Can Someone Live When Cancer Spreads To The Bones?
2.
The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment
3.
Lymphomatoid Papulosis: What You Need to Know
4.
Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence
5.
Bone Marrow Immune Niche Remodeling in Hematopoiesis
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Breast Cancer Awareness and Early Detection
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
4.
Common side effects of cancer treatment and how they are managed
5.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge